Molecule Arts Platform
PulseAugur coverage of Molecule Arts Platform — every cluster mentioning Molecule Arts Platform across labs, papers, and developer communities, ranked by signal.
1 day(s) with sentiment data
-
AI Drug Discovery Firm Derui Zhiyao Raises $52M Series B
Derui Zhiyao, a company focused on AI-driven drug discovery, has secured $52 million in Series B funding. The investment will be used to enhance their AI drug development engine, the Molecule Arts Platform (MAP), and it…
-
AI Drug Discovery Firm DeRuiz ZhiYao Secures $52M Series B
DeRuiz ZhiYao, a company focused on AI-driven drug discovery, has secured $52 million in Series B funding. The investment will be used to advance their proprietary AI drug development engine, MAP (Molecule Arts Platform…
-
AI drug developer Derui Zhiyao raises $52M for Phase III GLP-1 trial
Derui Zhiyao (德睿智药), an AI-native biopharmaceutical company, has secured $52 million in Series B funding. The capital will be used to enhance its AI drug discovery platform, Molecule Arts Platform (MAP), and advance its…